EdgarLookup

BERKSHIRE HATHAWAY INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that BERKSHIRE HATHAWAY INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
18%
Profit Margin
Net income ÷ revenue
5.5%
Return on Assets
Net income ÷ assets
0.7x
Debt-to-Equity
Total liabilities ÷ equity
+0%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $371.44B Mar 2, 2026
FY2025 Dec 31, 2024 $371.43B Mar 2, 2026
FY2025 Dec 31, 2023 $364.48B Mar 2, 2026
FY2024 Dec 31, 2022 $302.02B Feb 24, 2025
FY2023 Dec 31, 2021 $276.19B Feb 26, 2024
FY2020 Dec 31, 2020 $64.38B Mar 1, 2021
FY2020 Sep 30, 2020 $63.02B Mar 1, 2021
FY2020 Jun 30, 2020 $56.84B Mar 1, 2021
FY2020 Mar 31, 2020 $61.27B Mar 1, 2021
FY2020 Dec 31, 2019 $65.37B Mar 1, 2021

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $247.24B Mar 2, 2026
FY2025 Dec 31, 2024 $249.71B Mar 2, 2026
FY2025 Dec 31, 2023 $254.91B Mar 2, 2026
FY2024 Dec 31, 2022 $207.77B Feb 24, 2025
FY2023 Dec 31, 2021 $191.25B Feb 26, 2024
FY2022 Dec 31, 2020 $166.73B Feb 27, 2023
FY2021 Dec 31, 2019 $176.51B Feb 28, 2022
FY2020 Dec 31, 2018 $175.45B Mar 1, 2021

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $132.90B Feb 26, 2018
FY2017 Dec 31, 2016 $125.70B Feb 26, 2018
FY2017 Dec 31, 2015 $112.40B Feb 26, 2018
FY2016 Dec 31, 2014 $102.20B Feb 27, 2017
FY2015 Dec 31, 2013 $97.60B Feb 29, 2016
FY2014 Dec 31, 2012 $85.80B Mar 2, 2015

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $66.97B Mar 2, 2026
FY2025 Dec 31, 2024 $89.00B Mar 2, 2026
FY2025 Dec 31, 2023 $96.22B Mar 2, 2026
FY2024 Dec 31, 2022 ($22.76B) Feb 24, 2025
FY2023 Dec 31, 2021 $89.94B Feb 26, 2024
FY2020 Dec 31, 2020 $35.84B Mar 1, 2021
FY2020 Sep 30, 2020 $30.14B Mar 1, 2021
FY2020 Jun 30, 2020 $26.30B Mar 1, 2021
FY2020 Mar 31, 2020 ($49.75B) Mar 1, 2021
FY2020 Dec 31, 2019 $29.16B Mar 1, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 $20.08B Mar 1, 2013
FY2011 Dec 31, 2011 $17.18B Feb 27, 2012
FY2011 Dec 31, 2010 $17.27B Feb 27, 2012
FY2011 Dec 31, 2009 $11.16B Feb 27, 2012

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1,222.18B Mar 2, 2026
FY2025 Dec 31, 2024 $1,153.88B Mar 2, 2026
FY2024 Dec 31, 2023 $1,069.98B Feb 24, 2025
FY2024 Dec 31, 2022 $948.47B Feb 24, 2025
FY2023 Dec 31, 2021 $959.39B Feb 26, 2024
FY2022 Dec 31, 2020 $873.73B Feb 27, 2023
FY2021 Dec 31, 2019 $817.73B Feb 28, 2022
FY2020 Dec 31, 2018 $707.79B Mar 1, 2021
FY2019 Dec 31, 2017 $702.10B Feb 24, 2020
FY2018 Dec 31, 2016 $620.85B Feb 25, 2019

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $502.47B Mar 2, 2026
FY2025 Dec 31, 2024 $502.23B Mar 2, 2026
FY2024 Dec 31, 2023 $499.21B Feb 24, 2025
FY2023 Dec 31, 2022 $466.78B Feb 26, 2024
FY2020 Dec 31, 2020 $422.39B Mar 1, 2021
FY2020 Dec 31, 2019 $389.17B Mar 1, 2021
FY2019 Dec 31, 2018 $355.29B Feb 24, 2020
FY2018 Dec 31, 2017 $350.14B Feb 25, 2019
FY2017 Dec 31, 2016 $335.43B Feb 26, 2018
FY2016 Dec 31, 2015 $293.63B Feb 27, 2017

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $717.42B Mar 2, 2026
FY2025 Dec 31, 2024 $649.37B Mar 2, 2026
FY2024 Dec 31, 2023 $561.27B Feb 24, 2025
FY2023 Dec 31, 2022 $473.42B Feb 26, 2024
FY2022 Dec 31, 2021 $506.20B Feb 27, 2023
FY2023 Jan 1, 2021 $436.74B Feb 26, 2024
FY2021 Dec 31, 2020 $443.16B Feb 28, 2022
FY2020 Dec 31, 2019 $424.79B Mar 1, 2021
FY2019 Dec 31, 2018 $348.70B Feb 24, 2020
FY2018 Dec 31, 2017 $348.30B Feb 25, 2019

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2013 Dec 31, 2013 3,035 Mar 3, 2014
FY2013 Sep 30, 2013 3,074 Mar 3, 2014
FY2013 Jun 30, 2013 2,763 Mar 3, 2014
FY2013 Mar 31, 2013 2,977 Mar 3, 2014
FY2012 Dec 31, 2012 2,757 Mar 1, 2013
FY2012 Sep 30, 2012 2,373 Mar 1, 2013
FY2012 Jun 30, 2012 1,882 Mar 1, 2013
FY2012 Mar 31, 2012 1,966 Mar 1, 2013
FY2011 Dec 31, 2011 1,846 Feb 27, 2012
FY2011 Sep 30, 2011 1,380 Feb 27, 2012

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $31.58B Feb 26, 2018
FY2017 Dec 31, 2016 $28.05B Feb 26, 2018
FY2017 Dec 31, 2015 $67.16B Feb 26, 2018
FY2017 Dec 31, 2014 $60.03B Feb 26, 2018
FY2016 Dec 31, 2013 $45.91B Feb 27, 2017
FY2015 Dec 31, 2012 $46.99B Feb 29, 2016
FY2014 Dec 31, 2011 $37.30B Mar 2, 2015
FY2013 Dec 31, 2010 $38.23B Mar 3, 2014
FY2012 Dec 31, 2009 $30.56B Mar 1, 2013
FY2011 Dec 31, 2008 $25.54B Feb 27, 2012